Review
doi: 10.1007/BF01983300.
The pharmacology of ebselen
Affiliations
- PMID: 2058468
- DOI: 10.1007/BF01983300
Item in Clipboard
Review
The pharmacology of ebselen
Agents Actions.
1991 Jan.
No abstract available
Similar articles
-
Biological activities and clinical potential of Ebselen.Adv Exp Med Biol. 1990;264:193-7. doi: 10.1007/978-1-4684-5730-8_31. Adv Exp Med Biol. 1990. PMID: 2244495 Review. No abstract available.
-
Structure-activity relationships of a series of anti-inflammatory benzisoselenazolones (BISAs).Agents Actions. 1989 Jun;27(3-4):306-8. doi: 10.1007/BF01972806. Agents Actions. 1989. PMID: 2801314 No abstract available.
-
[Benzisoselenazolinones and their derivatives, a new series of anti-inflammatories and antioxidants].J Pharm Belg. 1990 Sep-Oct;45(5):322-30. J Pharm Belg. 1990. PMID: 2086756 French.
-
Horseradish peroxidase inhibition and antioxidant activity of ebselen and related organoselenium compounds.Bioorg Med Chem Lett. 2006 Oct 15;16(20):5334-8. doi: 10.1016/j.bmcl.2006.07.085. Epub 2006 Aug 17. Bioorg Med Chem Lett. 2006. PMID: 16919452
-
Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds.Arch Toxicol. 2011 Nov;85(11):1313-59. doi: 10.1007/s00204-011-0720-3. Epub 2011 Jul 1. Arch Toxicol. 2011. PMID: 21720966 Review.
Cited by
-
Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections.Free Radic Biol Med. 2020 Aug 20;156:107-112. doi: 10.1016/j.freeradbiomed.2020.06.032. Epub 2020 Jun 26. Free Radic Biol Med. 2020. PMID: 32598985 Free PMC article. Review.
-
Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines.Oncotarget. 2015 Jul 30;6(21):18418-28. doi: 10.18632/oncotarget.4099. Oncotarget. 2015. PMID: 26158899 Free PMC article.
-
Experimental and clinical evidence of antioxidant therapy in acute pancreatitis.World J Gastroenterol. 2012 Oct 21;18(39):5533-41. doi: 10.3748/wjg.v18.i39.5533. World J Gastroenterol. 2012. PMID: 23112545 Free PMC article. Review.
-
Toxicology and pharmacology of synthetic organoselenium compounds: an update.Arch Toxicol. 2021 Apr;95(4):1179-1226. doi: 10.1007/s00204-021-03003-5. Epub 2021 Apr 1. Arch Toxicol. 2021. PMID: 33792762 Free PMC article. Review.
-
Ebselen and congeners inhibit NADPH oxidase 2-dependent superoxide generation by interrupting the binding of regulatory subunits.Chem Biol. 2012 Jun 22;19(6):752-63. doi: 10.1016/j.chembiol.2012.04.015. Chem Biol. 2012. PMID: 22726689 Free PMC article.